TAM
SGYP

Telluride Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Telluride Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-67,288
Closed -$374K – 331
2013
Q4 		$374K Buy
+67,288
New +$290K 0.44% 46

Other funds holding SGYP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Telluride Asset Management's SGYP Position: Q1 2014 in Review

Telluride Asset Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2014, closing a stake of 67,288 shares — an estimated $374K sold.

Telluride Asset Management first reported a position in SGYP in Q4 2013 and held it in 1 quarter. The position peaked at $374K in Q4 2013. 80 funds tracked by Wall St. Rank hold SGYP as of Q1 2014.

  • Telluride Asset Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2014 after selling out during the quarter.
  • Telluride Asset Management sold 67,288 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2014, an estimated $374K.
  • Telluride Asset Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2013 and held it in 1 quarter.
  • Telluride Asset Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $374K in Q4 2013.
  • 80 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2014.

Based on Telluride Asset Management's 13F filing for Q1 2014, filed 14 May 2014.